Improved passive oral drug delivery via prodrugs

被引:49
作者
Taylor, MD
机构
[1] Parke-Davis Pharmaceutical Res. Div., Warner-Lambert Company, Ann Arbor, MI 48105
关键词
prodrug; passive absorption; oral absorption;
D O I
10.1016/0169-409X(95)00104-F
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Employing prodrugs to improve drug delivery and oral absorption, in particular, is a proven strategy. This review describes recent examples of prodrugs intended to improve oral delivery through enhanced passive transcellular absorption. The underlying biophysics of passive transcellur transport also is discussed as a framework for prodrug design.
引用
收藏
页码:131 / 148
页数:18
相关论文
共 96 条
[1]   INVESTIGATION OF N-[(ACYLOXY)ALKYL] ESTER AS A PRODRUG MODEL FOR DRUGS CONTAINING THE PHENYLTETRAZOLE MOIETY [J].
ALEXANDER, J ;
RENYER, ML ;
RORK, GS .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (06) :893-897
[2]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[3]   ENHANCED ORAL BIOAVAILABILITY OF DDI AFTER ADMINISTRATION OF 6-CL-DDP, AN ADENOSINE DEAMINASE-ACTIVATED PRODRUG, TO CHRONICALLY CATHETERIZED RATS [J].
ANDERSON, BD ;
MORGAN, ME ;
SINGHAL, D .
PHARMACEUTICAL RESEARCH, 1995, 12 (08) :1126-1133
[4]  
AUGUST EM, 1991, MOL PHARMACOL, V39, P246
[5]   PRODRUGS TO IMPROVE THE ORAL BIOAVAILABILITY OF A DIACIDIC NONPEPTIDE ANGIOTENSIN-II ANTAGONIST [J].
AUNGST, BJ ;
BLAKE, JA ;
ROGERS, NJ ;
SAITOH, H ;
HUSSAIN, MA ;
ENSINGER, CL ;
PRUITT, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (05) :763-767
[6]  
AUSTEL V, 1983, QUANTITATIVE STRUCTU, P437
[7]  
BAI JPF, 1994, PHARMACOKINETICS DRU, P189
[8]   NONPEPTIDE ANGIOTENSIN-II ANTAGONISTS - N-PHENYL-1H-PYRROLE DERIVATIVES ARE ANGIOTENSIN-II RECEPTOR ANTAGONISTS [J].
BOVY, PR ;
REITZ, DB ;
COLLINS, JT ;
CHAMBERLAIN, TS ;
OLINS, GM ;
CORPUS, VM ;
MCMAHON, EG ;
PALOMO, MA ;
KOEPKE, JP ;
SMITS, GJ ;
MCGRAW, DE ;
GAW, JF .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (01) :101-110
[9]   THE UTILITY OF THE PRODRUG APPROACH TO IMPROVE PEPTIDE ABSORPTION [J].
BUNDGAARD, H .
JOURNAL OF CONTROLLED RELEASE, 1992, 21 (1-3) :63-72
[10]  
BUNDGAARD H, 1991, Drugs of the Future, V16, P443